Brief: Pulse Biosciences Announces Collaboration With Cardionxt For NSPFA First-In-Human Atrial Fibrillation Study
02/10/2023 14:36
Oct 2 (Reuters) - Pulse Biosciences Inc PLSE.O :
* PULSE BIOSCIENCES ANNOUNCES COLLABORATION WITH CARDIONXT
FOR
NSPFA FIRST-IN-HUMAN ATRIAL FIBRILLATION STUDY
Source text for Eikon: ID:nBw5MRSJca
Further company coverage: PLSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulse Biosciences
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Pulse Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Pulse Biosciences Q2 net loss widens, cash position strengthens
Pulse Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants